1 Min Read
May 16 (Reuters) - VentriPoint Diagnostics Ltd:
* VENTRIPOINT RECEIVES MARKET CLEARANCE FROM US-FDA FOR COMPLETE HEART ANALYSIS SYSTEM USING 2D ULTRASOUND Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.